MTOR and neoplasm: After MEGF11 was knocked down in 4T1 cells (ΔMEGF11 4T1) (Supplementary Information 6), there was a decrease in implanted tumour weight (Fig. 7a) and AKT-mTOR signalling (Fig. 7b,c) compared to the wild type MEGF11.